ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

Examples Of CCOP Cancer Control Projects Listed

May 16, 1986

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

July 27, 2007

Supporters And A Critic Of Burzynski Comment

October 30, 1998

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

Powers, NCI Still Disagree On Organ Systems Provisions

April 22, 1983

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013